P03.03 MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery
S. Peters, David R. Spigel, Myung‐Ju Ahn, Masahiro Tsuboi, Jamie E. Chaft, David H. Harpole, Glenwood Goss, Fabrice Barlési, Christopher Abbosh, L. Poole, R. May, Phillip A. Dennis, Charles Swanton
Topics & Concepts
MedicineDurvalumabChemotherapyAdjuvantAdjuvant chemotherapyOncologyStage (stratigraphy)SurgeryInternal medicineLung cancerDiseaseCancerImmunotherapyBreast cancerBiologyNivolumabPaleontologyLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment